Pharmaceutical Business Investment Opportunities

- A company with well-established products having a presence in 5+ districts of Orissa with a strong distribution network covering more than 50 doctors with a team of well-trained medical representatives. - 1 product is under trademark registration. - We are selling around 7 products. - The products are certified by ISO and backed by an experienced team of skilled Pharma professionals and a quality research team. - We have been in the industry for over 16 years as a trusted name in the Pharmaceutical Industry.

- Have tied up with 200 doctors to promote products. - Have our presence in 8+ districts in Uttar Pradesh. - We have 7 products which are trademark registered. - In total, we sell 15 products. - The products are certified by ISO and backed by an experienced team of skilled pharma professionals and a quality research team. - We have been in the industry for over 10 years as a trusted name in the pharmaceutical industry.

- Business focused on developing a portfolio of supervision-free medications for pets. - The current product is a long-acting injectable designed to control pain in dogs with bone cancer. - This product can also be prescribed off-label for other painful conditions in pets. - The company plans to expand this drug delivery system to treat other conditions. - The drug delivery platform is based on technology originally developed for humans, and the CEO was part of the development team. - The company’s goal is to remove the burden of dosing, ensure adherence to prescriptions, and provide greater comfort to sick pets. - Formulation, manufacturing and marketing is all outsourced. - The company has developed prototypes of their products but is yet to conduct clinical trials and obtain FDA licensing. - The business model is business-to-business (B2B), with plans to sell directly to veterinarians.

1. Established firm: The company has a strong establishment, having been in the industry for 14 years, demonstrating stability and experience in the pharma marketing sector. 2. Wide client base: With over 250 clients, the company has a well-established customer base, indicating a strong market presence and potential for sustained revenue streams. 3. Niche Market Focus: The company specializes in marketing analgesic products to doctors and chemists, indicating a specific focus within the pharmaceutical marketing sector. 4. Growth Potential: With a relatively small team of 3 employees, there is potential for scalability and expansion, presenting an opportunity for investors to participate in the company's growth trajectory. 5. License: Drug License and GST Certificate.

- Pharmaceutical marketing firm operating in the eye care segment, headquartered in Mumbai, India. - The company has a total of 12+ products, with its top-selling products being tears eye drops, and antioxidant tablets. - The revenue model is based on marketing products to ophthalmologists, with patient sourcing through retailers upon prescription. - The company has a substantial market presence, meeting with 800 ophthalmologists every month and generating a monthly revenue of over INR 10 lakhs. - Operates with a business-to-business model, distributing its products through 17+ distributors in Mumbai who in turn supply to pharma retailers, resulting in an average of 60 to 70 orders per week. - The manufacturing of products is outsourced to two manufacturers under the company's own brand. - The promoter of the company has 12 years of experience in the pharmaceutical industry. - Business has a Drug License.

- Pharma manufacturing company, located in Nashik. - The plant is in its final stage of commissioning and will focus on the production of small volume parenterals in ampules, vials, PFS, and lyophilized products. - Technical inspection is pending, post which the business can obtain drug manufacturing license to start the manufacturing process. - Will be manufactured on a principle-to-principle and loan license basis for both local and export markets. - The product line includes human injectable products falling under drug categories such as antibiotics, steroids, analgesics etc. - Business model involves manufacturing products under the brand and formulation of other major pharmaceutical companies and supplying them for marketing and distribution. - The business is registered with the Ministry of Corporate Affairs (MCA), holds a Permanent Account Number (PAN), and is registered with the Micro, Small, and Medium Enterprises (MSME).

- We work with 50+ pharma companies for the distribution of their products. Abbott, Alcon, Emcure, Novartis, Pfizer, and Sun Pharma are some of the leading healthcare companies that we work with. - We deal with approximately 5,000 SKUs. - Our sales have increased significantly since our clientele has increased. - The funds will be utilized to invest in technological enablement, stocks and expand the customer base in Delhi NCR and Bangalore followed by other metro cities. - We are also planning to invest some funds into Medicine retail, which will significantly improve the bottom line. - With the investment, the company can grow beyond 20-30% YoY. - Exit will be given to the investors in 4-6 years with 18-21% annual IRR commitments. - The investors may co-invest with the other investors.

- We manufacture sleep-enhancing drinks. - The drink is manufactured on an OEM basis through our contract manufacturers. - Product is available across 600+ retail outlets in Malaysia including popular convenience chain stores and pharmacies. - Ready to sell in Singapore with required permits acquired. - Being a finalist of the FoodBev award in 2022 for most innovative functional beverage. - Formulated by proprietary formula with natural ingredients. - Planning to launch a series of branding and marketing strategies to boost brand awareness and offline product activation. - Have read offline channels to increase the physical selling spots of products. - Have the formula of new products ready for production and go-to-market. - The promoter has 2 years of experience in this industry and has previously been involved in the eCommerce and supply chain industry. - The business has a local authority certificate, factory certificate, and HACCP compliance certificate. - The business is currently operating at a loss as the business is still in the startup phase.

- Pharmaceutical business located in Dhaka, Bangladesh, has a rich history of 52 years in the industry, having recently been acquired by new management. - The brand, licenses, registrations, client base, and property have been transferred to the new owners. - Was supplying across Bangladesh, the Middle East, and African countries under its own branding. - The business was temporarily closed down three years ago due to personal reasons, but it is now in the process of re-establishing existing contracts and resuming production. - With 43 patents from medical authorities and various licenses including drug manufacturing, IRC, and Export & Import, the company has a strong foundation for pharmaceutical production and distribution. - The pharmaceutical company manufactured a diverse range of drug formulations, including liquid, capsule, tablet, suspension, syrup, injection, aerosol spray & inhaler, injections, bolus, premix powder, premix solutions, and bulk drugs. - Manufactured drug categories include - antibiotics, antibacterials, chemotherapeutics, antiprotozoals, antidiarrhoeal, antidiabetic, antihistamines, NSAIDs, antihypertensives, multivitamins etc. - The company possesses a broad client base, serving wholesalers, pharmacies, hospitals, clinics, and distributors, indicating its reach and potential for growth in both domestic and international markets. - Revenue will be primarily generated through the sale of generic medications, with a focus on cost-effective production and competitive pricing strategies, positioning the business well for market success. - The company is led by experienced professionals with a background in pharmaceutical manufacturing, research, and business management, indicating strong leadership and expertise within the organization. - Had established strong relationships with suppliers of raw materials, regulatory authorities, distribution partners, and healthcare institutions. Have started re-establishing existing contracts and will restart the supply. Will continue to manufacture under the existing brand. - Additionally, the current owners are into manufacturing and supplying medical equipment to hospitals and healthcare facilities, thereby providing an opportunity to establish new contracts.

- Business owner of a drug wholesale business planning to establish a pharmaceutical drug manufacturing plant. - The focus will be on creating a portfolio of drugs under the company's own brand name. - Initially, the manufacturing will concentrate on oral tablets and capsules, with future plans for expansion into other drug categories. - The company aims to supply its products to distributors across West Bengal, Jharkhand, Bihar, and Odisha. - Raw materials for the manufacturing process will be sourced from Ahmedabad and Visakhapatnam. - Will be obtaining drug license and FDA approval once the business launches.

- Established Ayurvedic products manufacturer and retailer based in New Delhi. - We have 850 outlets across India. - We are well placed in ecommerce platforms like Amazon, Flipkart, Snapdeal Shopclues and 1Mg. - We also export our products to London and Mauritius. - Our capacity is 50,000 units per week. - We have an Ayurvedic License and pollution certificate from the State Pollution Control Board. - We source our raw materials from the open market. - We have contract and daily wage employees. - Our operations are run from New Delhi.

- Wholesaler of generic medicines. - Our customers are pharmacies and hospitals. - 3 full-time employees including 1 accountant, and 2 marketing staff. - Licensed to sell generic pharmaceuticals.